Bacteria & Cancer
-
Upload
riccardo-guidi -
Category
Education
-
view
652 -
download
0
description
Transcript of Bacteria & Cancer
Role of bacteria in carcinogenesis
Riccardo GuidiFrontiers in Translational Medicine
Karolinska Institutet
Jan 7, 2013
epidemiological evidence
for H. pylori: Nat. Rev. Cancer 2, 28–37 (2002)
for Salmonella: Lancet 343, 83–84 (1994)
Am. J. Gastroenterol. 95, 784–787 (2000)J. Surg. Oncol. 93, 633–639 (2006)
for IBD: Cell Host & Microbe 3, 417–427 (2008)
Cancer 91, 854–862 (2001)Cancer 67, 2015–2020 (2006)
Salmonella enterica serovar Typhi
Inflammatory Bowel Disease
Barry J. Marshall and J. Robin Warren - Nobel 2005
Helicobacter pylori
increase risk of peptic ulcers --> gastric cancer
tumorigenesis is a step-wise transformation
normal colon’s cryptssmall tubular
adenomalarge tubular
adenomacarcinoma
loss of APCbeta-catetin
KRas activaiton
TSG101 loss
PIK3CA/PTENactivation
TP53/BAXloss
DNA hypomethylation
Genomic Instability
HISTO
LOG
ICA
L LEVELM
OLEC
ULA
R LEVEL
Weinberg RA, “The Biology of Cancer”, GS edition, 2007
tumorigenic barrier
1. senescence 2. cell death
normal colon’s cryptssmall tubular
adenomalarge tubular
adenomacarcinoma
the tumorigenic barrier mechanisms
sign
al
proliferation
DNA damage
senescence/death
DNA damage
senescence/death
proliferation
oncogene activation
genomic instability
DDR detection limit
Science 319, 1352–1355 (2008)
normal pre-cancerlesion
cancer
mutation
DNA damage
Cell 144, 646–674 (2011)
genomic instability is not the only enabling characteristic of tumorigenesis
chronic inflammation contributes to carcinogenesis
Cancer Res. 48, 4399–4404 (1988)
“There was a statistically significant deficit among cases in the use of aspirin-containing medication and vitamin supplements, and this was consistent for both colon and rectal cancer and for both males and females.”
CRCCTR
aspirin 20% 12%
RR
0.52
if you are taking aspirin, you have half the risk to be in the CRC group
p
>0.001
vitamin C 13% 4% 0.22 >0.001
if you are taking vitamin C, you have 1/4 the risk to be in the CRC group
epidemiological evidence
AOMAzoxymethane
DSSDextran sulfate sodium
+ Adenocarcinoma=
example of the colon adenocarcinoma
(kills enterocytes)/promoter mutagen/initiator
What exactly of the inflammatory process contributes to carcinogenesis?
animal model evidencechronic inflammation contributes to carcinogenesis
Greten, F. R., et al. (2004). Cell, 118(3), 285–296.
IKK
IkB
NF-κB NF-κB
IkBPP
ChemokinesCytokines
Cox2
CycD1MycCox2
Bcl-XL
IAP-1
inflammation proliferation anti-apoptosisTumor
progression
PRRTNF-receptor
Dangerous Signals
dissecting the inflammatory pathway: NF-kB
gene transcription
Nat. Immunol. 12, 715–723 (2011)
cyto
sol
nucl
eus
tumorigenic barrier
IL-1IL-8
NF-κB inhibition slow down CRC progression
AOMAzoxymethane
DSSDextran sulfate sodium
+ Adenocarcinoma=
Greten, F. R., et al. (2004). Cell, 118(3), 285–296.
tumors are smaller because a) cell death? b) reduced proliferation?
Ikkβ!wt!
IkkβΔ!Ep!
Ikkβ wt! IkkβΔ Ep!
Tunnel staining#
Ikkβ wt! IkkβΔ Ep!
Teresa Frisan, CMB, KI
Ikkβ wt!
IkB DM ON!IkB DM ON!IkB DM ON!
IkB DM OFF!IkB DM OFF!CTR!
IκB wt!
IκB DM!ON!
IκB DM!OFF!
WT Ikk KD
In this model, NF-kB plays a role in protecting cell from apoptosis! NF-KB
Inflammation Toxins
How do bacteria contribute to cancer?
Macrophage!
Intraepitelial T cells!
Peyer’s patch!
LAMINA PROPRIA!
MUCOSAL EPITHELIUM!
M cell!
DC!
PMN!
IL1!
TNFα!
IL6!
IL8!
TLRs!
IL6!TNFα!
STAT3!NFκB!
PRR
TRUC model for Ulcerative Colitis
Garrett, W. S., et al. Cancer Cell, 16(3), 208–219.
T-bet -/- + RAG2 -/- = TRUC --> Ulcerative colitis
lack adaptive immunity(lack of Treg)
host-commensal homeostasis(high TNF-alfa)
bact
eroi
dete
sfir
mic
utes
TRUC model for Ulcerative Colitis
Garrett, W. S., et al. Cancer Cell, 16(3), 208–219.
T-bet -/- + RAG2 -/- = TRUC --> Ulcerative colitis
lack adaptive immunity(lack of Treg)
host-commensal homeostasis(high TNF-alfa)
CTR TRUC
antibiotic treatment reduces cancer development
Inflammation Toxins
How do bacteria contribute to cancer?
(bacterial genotoxin)
Bacterial genotoxins: cytolethal distending toxin (CDT) and Colibactin!
CdtB!
CdtC!CdtA!
clbM! clbL!
clbK! clbJ! clbI! clbH!
clbG! clbF!clbE! clbD!
clbC! clbB!
clbR! clbA!
clbN!clbO!
clbP!clbQ!
ORF2!
intP4!
ORF21!ORF22!ORF23!
Accessory proteins!Polyketide magasynthase PKS! Non ribosomal peptide magasynthase (NRPS)!Hybrid NRPS/PKS!
CDT is a trimeric toxin. CdtB: active subunit, homologous to DNase I, CdtA/CdtC: binding to cell surface!
Produced by several Gram negative bacteria, including Escherichia coli, Salmonella typhi, Campylobacter sp, Helicobacter sp!
Colibactin produced by commensal strains of E. coli!
Synthesized by a cluster of genes encoding for non ribosomal peptide synthetases (polyketide peptide) !
(and pathogenic)
1. Infection with Colibactin pos.ve strain induces DNA damage in vivo!
2. Infection with Colibactin pos.ve strain induces anaphase bridges and promote anchorage independent growth!
PNAS (2010) 107, 11537-11542!
wt
+ Clb +Clb -
Pathogenic E.coli expressing Colibactin induce DNA damage and promotes genomic instability
PNAS 107, 11537–11542 (2010)
Colibactin expressing E.coli populates inflamed bowelMice with inflammatory bowel disease contain higher proportions of toxin-producing bacteria
il10-/-
microbiota?wt
Does this have a relevance in humans?
AOM+ +Clb +
Clb -
germ-freeil10-/-
CDT carcinogenic properties in vitro
Cell. Microbiol. (2012).doi:10.1111/cmi.12034
6 months
CDT CDT CDT CDT CDT
1. genomic instability 2. gene mutations
3. anchorage independent growth
wt
+ CDT +CDT -
H. hepaticus chronic infection
Cell. Microbiol. 9, 2070–2080 (2007).
-CDT
+CDT -C
DT+C
DT
-CDT
+CDT
-CDT
+CDT
CDT carcinogenic properties in vivo
Home-taking messages
• Genomic instability and chronic inflammation are enabling hallmarks of cancer• Chronic activation of NF-kB leads to overcome the tumorigenic barrier• Bacteria may contribute to cancer with• promotion of inflammation (via PRR)• toxin production that directly cause DNA damage and genomic instability
Thanks